Trial Profile
Effect of rituximab monotherapy in patients with relapsed indolent Non-Hodgkin Lymphomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 24 Apr 2015 New trial record